Printer Friendly

Bill exempts user fees.

A bipartisan duo of House members has reintroduced the Food and Drug Administration Safety Over Sequestration Act, or FDA SOS Act, which exempts FDA user fees from sequestration. FDA user fees are 100% industry-financed and are used specifically for the approval of safe and effective drugs and devices. In the event of another sequester like the budget sequestration of 2013, the FDA could lose tens of millions of dollars, preventing it from meeting its congressionally mandated responsibilities and leaving patients without lifesaving therapies. The authors of the bill, Reps. Anna Eshoo (D., Calif.) and Leonard Lance (R., N.J.), have concerns that a repeat of the 2013 sequester could reduce not only the FDA's budget from Congress, but also reduce industry-financed user fees to the agency.

COPYRIGHT 2015 Racher Press, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Digest
Publication:Chain Drug Review
Date:Mar 16, 2015
Words:126
Previous Article:Assessing the flu vaccine.
Next Article:Consumer genetic test wins OK.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters